Hiroko Asanuma

Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Breast Cancer Cells

Hiroko Asanuma, Toshihiko Torigoe, Kenjiro Kamiguchi et al. · Cancer Research · 2005 · 199 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Tetsuhiro Tsuruma, Fumitake Hata, Toshihiko Torigoe et al. · Journal of Translational Medicine · 2004 · 181 citations · Full text

Medicine, Immunology, Oncology +17

A Novel CIC-FOXO4 Gene Fusion in Undifferentiated Small Round Cell Sarcoma

Shintaro Sugita, Yasuhito Arai, Akiko Tonooka et al. · The American Journal of Surgical Pathology · 2014 · 172 citations

Veterinary Medicine, Oncology, Pathology +17

Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5

Tomohide Tsukahara, Satoshi Kawaguchi, Toshihiko Torigoe et al. · Cancer Science · 2006 · 143 citations · Full text

Life Sciences, Medicine, Immunology +18

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma

Satoshi Kawaguchi, Takuro Wada, Kazunori Ida et al. · Journal of Translational Medicine · 2005 · 138 citations · Full text

Life Sciences, Immunology, Oncology +17